Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release.
What is Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release used for?
PROTONIX For Delayed-Release Oral Suspension and PROTONIX Delayed-Release Tablets are indicated for: PROTONIX is a proton pump inhibitor indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) (1.1) Maintenance of Healing of Erosive Esophagitis (1.2) Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (1.3) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) PROTONIX is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of PROTONIX may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been established. 1.2 Maintenance of Healing of Erosive Esophagitis PROTONIX is indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD. Controlled studies did not extend beyond 12 months. 1.3 Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome PROTONIX is indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Is using Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release safe or dangerous while breastfeeding?
Pantoprazole is the only one ingredient used in manufacturing of Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Pantoprazole it is safe to use Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release while lactating. We suggest you to check further details below about Pantoprazole usage in breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Pantoprazole and its metabolites are excreted in the milk of rats. Pantoprazole excretion in human milk has been detected in a study of a single nursing mother after a single 40 mg oral dose. The clinical relevance of this finding is not known. Many drugs which are excreted in human milk have a potential for serious adverse reactions in nursing infants. Based on the potential for tumorigenicity shown for pantoprazole in rodent carcinogenicity studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the benefit of the drug to the mother.
Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release Breastfeeding Analsys
SafeCAS Number: 102625-70-7
Due to a high serum-protein-binding capacity, excretion into breast milk is non-significant without side-effects among breastfed infants from treated mothers. Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Pantoprazole that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food. No effect on Prolactin secretion has been observed. Other formulations of Pantoprazole without anti-acid protection are destroyed in the stomach.
Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release Breastfeeding Analsys - 2
CAS Number: 102625-70-7
Maternal pantoprazole doses of 40 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants.
I already used Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release and meanwhile I breastfed my baby should I be concerned?
Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.
My doctor has prescribed me Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release, what should I do?
Usage of Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release is safe for nursing mothers and baby, No worries.
If I am using Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release, will my baby need extra monitoring?
No
Who can I talk to if I have questions about usage of Protonix Delayed-release | Pantoprazole Sodium Tablet, Delayed Release in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week